Both Wegovy tablets and orforglipron carry warnings around important risks and require clinical screening before prescribing
The promise is simple, but the reality leaves a lot of unanswered questions
January to May 2026 (In Progress): Remaining TRIUMPH Phase 3 trials (1, 2, and 3) are being completed
Aim for a palm-sized portion of lean protein in most meals, and pair with fiber-rich sides and hydration for comfort
CrossRef Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Giorgia Litrico, Luigi Piero Greco, Luisa Gallo, Gaetano La Greca, Saverio Latteri Heliyon.2024
Glucagon like peptide 1 receptor agonists (GLP-1 RAs) are also effective in terms of glycemic control and associated with weight loss and low risk of hypoglycemia